黄酮类化合物抗肝纤维化潜力综述
本文综述黄酮类化合物在肝纤维化中的作用机制与潜力,通过多数据库检索相关文献。约86种中药来源的黄酮具有抗纤维化作用,机制涉及抗炎、抗氧化及抑制肝星状细胞活化。但药代动力学研究少,多数为临床前研究,缺乏临床试验数据。
要点
- 约86种中药黄酮显示抗肝纤维化作用
- 机制包括抗炎、抗氧化、抑制肝星状细胞活化
- 临床证据缺乏,需进一步药代动力学研究
核心结论
- 黄酮类化合物在肝纤维化中具有潜在保护作用,但尚缺乏可靠的临床试验数据支持新药开发。
研究设计与样本
- 综述性研究,通过Google Scholar、Elsevier、PubMed、CNKI、万方、SciFinder和Web of Science等数据库检索文献。
主要发现
- 约86种中药来源的天然黄酮具有显著抗纤维化作用。
- 机制可能通过抗炎、抗氧化、抑制肝星状细胞活化和清除活化肝星状细胞实现。
关键数值与推荐
- 药代动力学研究在肝纤维化模型中较少,多数研究限于临床前阶段。
临床怎么用
- 黄酮类化合物可作为肝纤维化治疗的潜在候选,但需进一步研究生物利用度和临床转化。
局限性
- 缺乏临床试验数据,药代动力学研究不足,多数为临床前研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Hepatic fibrosis is a pathophysiological process of extracellular matrix abnormal deposition induced by multiple pathogenic factors. Currently, there is still a lack of effective and non-toxic drugs for treating fibrosis in clinic. Flavonoids are polyphenolic compounds synthesized in plants and modern pharmacological studies confirmed flavonoids exhibit potent hepatoprotective effect. PURPOSE: Summarize literature to elaborate the mechanism of HF and evaluate the potential of flavonoids in HF, aiming to provide a new perspective for future research. METHODS: The literatures about hepatic fibrosis and flavonoids are collected via a series of scientific search engines including Google Scholar, Elsevier, PubMed, CNKI, WanFang, SciFinder and Web of Science database. The key words are "flavonoids", "hepatic fibrosis", "pharmacokinetic", "toxicity", "pathogenesis" "traditional Chinese medicine" and "mechanism" as well as combination application. RESULTS: Phytochemical and pharmacological studies revealed that about 86 natural flavonoids extracted from Chinese herbal medicines possess significantly anti-fibrosis effect and the mechanisms maybe through anti-inflammatory, antioxidant, inhibiting hepatic stellate cells activation and clearing activated hepatic stellate cells. CONCLUSIONS: This review summarizes the flavonoids which are effective in HF and the mechanisms in vivo and in vitro. However, fewer studies are focused on the pharmacokinetics of flavonoids in HF model and most studies are limited to preclinical studies, therefore there is no reliable data from clinical trials for the development of new drugs. Further in-depth research related it can be conducted to improve the bioavailability of flavonoids and serve the development of new drugs.
引用
- Wenbo Z, Jianwei H, Hua L, et al. The potential of flavonoids in hepatic fibrosis: A comprehensive review. Phytomedicine. 2024. PMID: 39146877. doi:10.1016/j.phymed.2024.155932
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。